Endocrinología

Kevin A Huynh, Jin Al-Gully, José M Montero-Cabezas, Linda E Scheffers, Marco J T Verstegen, Nienke R Biermasz, Eva C Coopmans, The effect of first intervention on cardiac parameters in patients with acromegaly: a systematic review, European Journal of Endocrinology, Volume 192, Issue 2, February 2025, Pages S1–S14, https://doi.org/10.1093/ejendo/lvaf009

Glintborg D, Christensen LL, Andersen MS. Transgender healthcare: metabolic outcomes and cardiovascular risk. Diabetologia. 2024 Nov;67(11):2393-2403. doi: 10.1007/s00125-024-06212-6. Epub 2024 Jul 3. PMID: 38958699.

DOI: 10.1007/s00125-024-06212-6

Lee más sobre Transgender healthcare: metabolic outcomes and cardiovascular risk

Masana, Luis et al.

The Lancet Diabetes & Endocrinology, Volume 12, Issue 12, 880 - 889

DOI: 10.1016/S2213-8587(24)00233-X

Lee más sobre Lomitapide for the treatment of paediatric patients with homozygous familial hypercholesterolaemia (APH-19): results from the efficacy phase of an open-label, multicentre, phase 3 study

Anand Vaidya, Robert M Carey

The Journal of Clinical Endocrinology & Metabolism. December 2020

https://doi.org/10.1210/clinem/dgaa606

Lee más sobre Evolution of the Primary Aldosteronism Syndrome: Updating the Approach

Marta Araujo-Castro et al. Endocrine. 2024 Jul.

https://link.springer.com/article/10.1007/s12020-024-03751-1

Lee más sobre Screening and diagnosis of primary aldosteronism. Consensus document of all the Spanish Societies involved in the management of primary aldosteronism

European Journal of Endocrinology, Volume 191, Issue 4, October 2024, Pages 389–398, https://doi.org/10.1093/ejendo/lvae113

Lee más sobre Management and follow-up strategies for patients with head and neck paraganglioma

The New England Journal of Medicine

Nov 2023

Lee más sobre Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes

Journal of Hepatology
Junio 2024

Lee más sobre EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)

The New England Journal of Medicine

Junio 2024

Lee más sobre Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis

Suscribirse a Endocrinología

Agenda

Marzo 2025

Lun	Mar	Mié	Jue	Vie	Sáb	Dom
24	25	26	27	28	1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30
31	1	2	3	4	5	6

Ver Agenda

Endocrinología

The effect of first intervention on cardiac parameters in patients with acromegaly: a systematic review

Selenium Supplementation in Patients with Hashimoto Thyroiditis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

Transgender healthcare: metabolic outcomes and cardiovascular risk

Lomitapide for the treatment of paediatric patients with homozygous familial hypercholesterolaemia (APH-19): results from the efficacy phase of an open-label, multicentre, phase 3 study

Evolution of the Primary Aldosteronism Syndrome: Updating the Approach

Screening and diagnosis of primary aldosteronism. Consensus document of all the Spanish Societies involved in the management of primary aldosteronism

Management and follow-up strategies for patients with head and neck paraganglioma

Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes

EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)

Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis

Marzo 2025

Publicaciones Científicas

Notícias